Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...
2d
GlobalData on MSNJ&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ resultsThe company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...
Investigation under way into trio of oncologists at same hospital who presented symptoms of highly toxic E coli strain.
Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...
Doctor’s age and bacteria’s nature prompt check of possible causes such as chemical exposure, autoimmune issues and radiation ...
Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by the problem pathogen Escherichia coli looks ...
The avian specific form of E. coli can lead to an infection called colibacillosis that can cause septicemia, organ failure and death.
By combining MERFISH imaging with expansion microscopy, researchers have unlocked a new way to study bacteria at the ...
An attorney for Harris County, Texas, recently filed a lawsuit against a local utility after learning that E. coli was detected in the city waterways at 1,000 times the legal limit. Newsweek reached ...
5d
Hosted on MSNThe Antibiotic Arms Race: Can Science Stay Ahead of Rapidly Evolving Antibiotic-Resistant Bacteria?A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...
The nationwide recall affected Trader Joe's products including the White Meat Chicken Salad, Harvest Salad With Grilled ...
Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results